Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
Top Cited Papers
Open Access
- 5 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (7), 451-459
- https://doi.org/10.1093/jnci/djj101
Abstract
Background: Vitamin D has potent anticancer properties, especially against digestive-system cancers. Many human studies have used geographic residence as a marker of solar ultraviolet B and hence vitamin D exposure. Here, we considered multiple determinants of vitamin D exposure (dietary and supplementary vitamin D, skin pigmentation, adiposity, geographic residence, and leisure-time physical activity—to estimate sunlight exposure) in relation to cancer risk in the Health Professionals Follow-Up Study. Methods: Among 1095 men of this cohort, we quantified the relation of these six determinants to plasma 25-hydroxy-vitamin D [25(OH)D] level by use of a multiple linear regression model. We used results from the model to compute a predicted 25(OH)D level for each of 47 800 men in the cohort based on these characteristics. We then prospectively examined this variable in relation to cancer risk with multivariable Cox proportional hazards models. Results: From 1986 through January 31, 2000, we documented 4286 incident cancers (excluding organ-confined prostate cancer and nonmelanoma skin cancer) and 2025 deaths from cancer. From multivariable models, an increment of 25 nmol/L in predicted 25(OH)D level was associated with a 17% reduction in total cancer incidence (multivariable relative risk [RR] = 0.83, 95% confidence interval [CI] = 0.74 to 0.92), a 29% reduction in total cancer mortality (RR = 0.71, 95% CI = 0.60 to 0.83), and a 45% reduction in digestive-system cancer mortality (RR = 0.55, 95% CI = 0.41 to 0.74). The absolute annual rate of total cancer was 758 per 100 000 men in the bottom decile of predicted 25(OH)D and 674 per 100 000 men for the top decile; these respective rates were 326 per 100 000 and 277 per 100 000 for total cancer mortality and 128 per 100 000 and 78 per 100 000 for digestive-system cancer mortality. Results were similar when we controlled further for body mass index or physical activity level. Conclusions: Low levels of vitamin D may be associated with increased cancer incidence and mortality in men, particularly for digestive-system cancers. The vitamin D supplementation necessary to achieve a 25(OH)D increment of 25 nmol/L may be at least 1500 IU/day.Keywords
This publication has 45 references indexed in Scilit:
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerNew England Journal of Medicine, 2006
- Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate CancerCancer Research, 2005
- The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)Cancer Causes & Control, 2005
- Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Vitamin D3from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)Cancer Causes & Control, 2004
- Reproducibility and Validity of a Self-Administered Physical Activity Questionnaire for Male Health ProfessionalsEpidemiology, 1996
- Validity of Self-Reported Waist and Hip Circumferences in Men and WomenEpidemiology, 1990
- Colonic Hyperplasia and Hyperproliferation Induced by a Nutritional Stress Diet With Four Components of Western-Style DietJNCI Journal of the National Cancer Institute, 1990
- SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDYThe Lancet, 1989
- INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3The Lancet, 1982